Role of Pre-operative Meta-Iodo Benzyl Guanidine (MIBG) in Biochemically Proven and Anatomically Localized Adrenal Pheochromocytoma View PDF

^*Kul Ranjan Singh
Department Of Endocrine Surgery, King George's Medical University, Lucknow, India

^*Corresponding Author:

Kul Ranjan Singh
Department Of Endocrine Surgery, King George's Medical University, Lucknow, India
Email:kulranjan@hotmail.com

Published on: 2016-10-03

Abstract

Radio labeled metaiodobenzylguanidine scintigraphy (MIBG) is used for used to image pheochromocytomas. While computed tomography (CECT) or magnetic resonance imaging (MRI) usually localizes the tumor, MIBG is often obtained to rule out multifocal and metastatic disease and to corroborate anatomic imaging with functional data. Since the utility of routine MIBG is questionable in the pre-operative setting, the aim of this retrospective analysis was to look at this issue.

Keywords

Pheochromocytoma; Metaiodobenzylguanidine scintigraphy; Adrenal; Work up

Introduction

Pheochromocytoma (PCC) is an uncommon and deceptive neuroendocrine tumor that develops from the chromaffin cells in the sympathetic system [1]. Diverse manifestations lead to a significant delay in diagnosis and definitive treatment [2]. PCC has rightfully earned the title of “Great Mimic” and often causes morbidity and mortality if the diagnosis is missed or patients are treated inappropriately